Analystreport

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com